Skip to content

Biomarkers of Kidney Function in Transplant Medicine

Biomarkers of Kidney Function in Transplant Medicine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05538234
Enrollment
30
Registered
2022-09-13
Start date
2023-01-01
Completion date
2026-03-31
Last updated
2023-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

organ donor, organ recipient, transplant medicine, acute kidney injury

Brief summary

Biomarkers of kidney function in transplant medicine is an international, multicentre, observational, non-interventional study. The project is aimed at monitoring biomarkers of acute kidney dysfunction in deceased organ donors, living organ donors, and organ recipients.

Detailed description

The study is observational, without any changes from the standard care, including only selected laboratory assessments, from standard blood samples collected from the donors/recipients. Informed consent will be required from living donors and recipients. The mainly used current criteria of organ acceptability in transplant medicine include urine output and laboratory parameters of acute kidney dysfunction - serum levels of urea and creatinine. Literary sources show that these classic criteria of kidney dysfunction develop only with a significant reduction of (glomerular and tubular) kidney functions and return to normal only slowly after the function of the kidneys has been restored. New possibilities of early kidney dysfunction diagnostics are being studied, using more sensitive tests - determination of biomarkers of acute kidney dysfunction. These may serve as decisive criteria for the safe use of organs from so-called marginal donors and identify early serious impairment of kidney function in donors with preserved urine output, without fulfilled criteria of acute kidney injury.

Interventions

DIAGNOSTIC_TESTLaboratory values - baseline

Baseline laboratory values will be obtained

OTHERMedical information 12 hours before organ harvesting

* average hourly diuresis * hypotension MAP\<65 Torr longer than 30 minutes (YES/NO) * Furosemide administration (YES/NO) * Mannitol administration (YES/NO) * administration of anti-diuretic hormone (YES/NO) * administration of vasopressors (YES/NO) * polyuria \>3ml/kg/h (YES/NO) * nephrotoxic agents during hospitalization (YES/NO)

DIAGNOSTIC_TESTLaboratory values - 12 hours after reperfusion

Laboratory values will be obtained 12 hours after reperfusion

DIAGNOSTIC_TESTLaboratory values - 48 hours after reperfusion

Laboratory values will be obtained 48 hours after reperfusion

DIAGNOSTIC_TESTLaboratory values - 7 days after reperfusion

Laboratory values will be obtained 7 days after reperfusion

DIAGNOSTIC_TESTLaboratory values - 90 days after reperfusion

Laboratory values will be obtained 90 days after reperfusion

OTHERMedical information during organ harvesting/transplantation

Medical information during organ harvesting/transplantation * hypotension MAP 65 Torr \> 5 minutes (YES/NO) * vasopressor support (YES/NO, duration in minutes)

PROCEDUREOrgan harvesting

Organ harvesting for transplant

PROCEDUREOrgan transplantation

Transplantation of the harvested organ

Sponsors

University Hospital Ostrava
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* age 18+ * signed Informed Consent in case of living organ donors and recipients * fulfillment of all legal requirements for organ harvesting from a deceased donor * fulfillment of all ethical principles of end-of-life patient care * medical suitability of organs for transplant use

Exclusion criteria

\- disapproval of family members with the enrolment of the patient in the study

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of kidney dysfunction biomarkersup to 90 days after the procedureSensitivity of kidney dysfunction biomarkers will be assessed using the Kidney Donor Risk Index and Kidney Donor Profile Index

Secondary

MeasureTime frameDescription
Comparison of levels of kidney dysfunction biomarkers between DBD donors (Donation after Brain Death) and DCD donors (Donation after Cardiac Deathduring baseline data collectionlevels of kidney dysfunction biomarkers between DBD donors (Donation after Brain Death) and DCD donors (Donation after Cardiac Death will be assessed.
Correlation of Acute Kidney Injury biomarkers in DCD donors with the time of warm ischemiaduring organ harvestingCorrelation of Acute Kidney Injury biomarkers in DCD donors with the time of warm ischemia will be assessed.
Predictive value of Acute Kidney Injury biomarkers in organ recipientsup to 90 days after transplantationThe predictive value of Acute Kidney Injury biomarkers in organ recipients for worsened function of the transplanted kidney will be assessed
Association between donor kidney dysfunction with selected risk factorsup to 90 days after transplantationAssociation between donor kidney dysfunction with selected risk factors will be assessed (ion disbalance, circulatory instability)

Countries

Czechia

Contacts

Primary ContactJiří Hynčica
jiri.hyncica@fno.cz0042059737

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026